Richard J. O'Reilly, M.D. - Publications

1973- Pediatrics Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
 1973- Immunology Sloan Kettering Institute, New York, NY, United States 
Pediatric oncology, bone marrow transplantation, T cell therapy

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.


Year Citation  Score
2021 Fabrizio VA, Rodriguez-Sanchez MI, Mauguen A, Dahi PB, Doubrovina E, O'Reilly RJ, Prockop SE. Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses. Blood Advances. 5: 496-503. PMID 33496746 DOI: 10.1182/bloodadvances.2020002735  0.52
2020 de Koning C, Prockop S, Roessel IV, Kernan NA, Klein E, Langenhorst J, Szanto CL, Belderbos ME, Bierings M, Boulad F, Bresters D, Cancio MI, Curran KJ, Kollen WJ, O'Reilly RJ, et al. CD4+ T-cell reconstitution predicts Survival Outcomes after acute Graft-versus-Host-Disease; a dual center validation. Blood. PMID 33150379 DOI: 10.1182/blood.2020007905  0.48
2020 Dalton T, Doubrovina E, Pankov D, Reynolds RC, Scholze H, Selvakumar A, Vizconde T, Savalia B, Dyomin V, Weigel C, Oakes CC, Alonso A, Elemento O, Pan H, Phillip JM, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to viral directed immunotherapy. Blood. PMID 32157281 DOI: 10.1182/blood.2019004126  0.52
2019 Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, et al. Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant. The Journal of Clinical Investigation. PMID 31689242 DOI: 10.1172/JCI121127  0.52
2019 Curran KJ, Margossian S, Kernan NA, Silverman LB, Williams DA, Shukla NN, Kobos R, Forlenza C, Steinherz P, Prockop S, Boulad F, Spitzer B, Cancio MI, Boelens JJ, Kung AL, et al. Toxicity and Response following CD19-specific CAR T cells in pediatric/young adult relapsed/refractory B-ALL. Blood. PMID 31650176 DOI: 10.1182/blood.2019001641  0.56
2019 O'Reilly RJ, Prockop S, Hasan A, Doubrovina E. Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction. Bone Marrow Transplantation. 54: 759-764. PMID 31431697 DOI: 10.1038/s41409-019-0614-1  0.52
2018 Modak S, Le Luduec JB, Cheung IY, Goldman DA, Ostrovnaya I, Doubrovina E, Basu E, Kushner BH, Kramer K, Roberts SS, O'Reilly RJ, Cheung NV, Hsu KC. Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study. Oncoimmunology. 7: e1461305. PMID 30221057 DOI: 10.1080/2162402X.2018.1461305  0.52
2018 Haddad E, Logan BR, Griffith LM, Buckley RH, Parrot RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, et al. SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study. Blood. PMID 30154114 DOI: 10.1182/blood-2018-03-840702  0.32
2018 Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, et al. B cell differentiation and IL-21 response in / SCID patients after hematopoietic stem cell transplantation. Blood. PMID 29728406 DOI: 10.1182/blood-2017-10-809822  0.32
2018 Ahmed M, Lopez-Albaitero A, Pankov D, Santich BH, Liu H, Yan S, Xiang J, Wang P, Hasan AN, Selvakumar A, O'Reilly RJ, Liu C, Cheung NV. TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. Jci Insight. 3. PMID 29467338 DOI: 10.1172/jci.insight.97805  0.52
2017 Pankov D, Sjöström L, Kalidindi T, Lee SG, Sjöström K, Gardner R, McDevitt MR, O'Reilly R, Thorek DLJ, Larson SM, Veach D, Ulmert D. In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME). Oncotarget. 8: 65917-65931. PMID 29029482 DOI: 10.18632/oncotarget.19579  0.56
2017 Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, et al. Immune Reconstitution and Survival of 100 SCID Patients Post Hematopoietic Cell Transplant: A PIDTC Natural History Study. Blood. PMID 29021228 DOI: 10.1182/blood-2017-05-781849  0.32
2017 Goldberg JD, Zheng J, Ratan R, Small TN, Lai KC, Boulad F, Castro-Malaspina H, Giralt SA, Jakubowski AA, Kernan NA, O'Reilly RJ, Papadopoulos EB, Young JW, van den Brink MR, Heller G, et al. Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia & Lymphoma. 1-13. PMID 28073320 DOI: 10.1080/10428194.2016.1265113  0.4
2016 Hasan AN, Selvakumar A, Shabrova E, Liu XR, Afridi F, Heller G, Riviere I, Sadelain M, Dupont B, O'Reilly RJ. Soluble and membrane bound IL-15 Rα/IL-15 complexes mediate proliferation of high avidity central memory CD8(+) T-cells for adoptive immunotherapy of cancer and infections. Clinical and Experimental Immunology. PMID 27227483 DOI: 10.1111/cei.12816  0.56
2016 Spitzer B, Perales MA, Kernan NA, Prockop SE, Zabor EC, Webb N, Castro-Malaspina H, Papadopoulos EB, Young JW, Scaradavou A, Kobos R, Giralt SA, O'Reilly RJ, Boulad F. Second allogeneic stem cell transplantation for acute leukemia using a chemotherapy only cytoreduction with clofarabine, melphalan, and thiotepa. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27184623 DOI: 10.1016/j.bbmt.2016.05.001  0.68
2016 O'Reilly RJ, Prockop S, Hasan AN, Koehne G, Doubrovina E. Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections. Bone Marrow Transplantation. PMID 27042851 DOI: 10.1038/bmt.2016.17  0.52
2016 Anur P, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney J, Singh B, Prockop SE, Kernan NA, Scaradavou A, Kobos R, Curran K, Ruggiero J, Zakak N, O'Reilly RJ, et al. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. Bone Marrow Transplantation. PMID 26999465 DOI: 10.1038/bmt.2016.32  0.68
2016 Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CG, Scallion MI, Doubrovin M, Heller G, Younes A, et al. Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses. Cancer Research. 76: 377-89. PMID 26744524 DOI: 10.1158/0008-5472.CAN-14-2814  0.52
2016 Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CGK, Scallion MI, Doubrovin M, Heller G, Younes A, et al. Characterization of a c-Rel inhibitor that mediates anticancer properties in hematologic malignancies by blocking NF-κB-controlled oxidative stress responses Cancer Research. 76: 377-389. DOI: 10.1158/0008-5472.CAN-14-2814  0.52
2015 Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, et al. Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. PMID 26389576 DOI: 10.1038/nbt.3349  0.52
2015 Ponce DM, Hilden P, Devlin SM, Maloy M, Lubin M, Castro-Malaspina H, Dahi P, Hsu K, Jakubowski AA, Kernan NA, Koehne G, O'Reilly RJ, Papadopoulos EB, Perales MA, Sauter C, et al. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26238810 DOI: 10.1016/j.bbmt.2015.07.029  0.68
2015 Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, Goldberg JD, Perales MA, Ponce DM, Sauter CS, Maloy MA, Herman DY, Klimek V, Young JW, O'Reilly RJ, et al. CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26187863 DOI: 10.1016/j.bbmt.2015.07.010  0.68
2015 O'Reilly RJ, Koehne G, Hasan AN, Doubrovina E, Prockop S. T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells. Bone Marrow Transplantation. 50: S43-50. PMID 26039207 DOI: 10.1038/bmt.2015.95  0.52
2015 Koehne G, Hasan A, Doubrovina E, Prockop S, Tyler E, Wasilewski G, O'Reilly RJ. Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1663-78. PMID 26028505 DOI: 10.1016/j.bbmt.2015.05.015  0.52
2015 Harnicar S, Ponce DM, Hilden P, Zheng J, Devlin SM, Lubin M, Pozotrigo M, Mathew S, Adel N, Kernan NA, O'Reilly R, Prockop S, Scaradavou A, Hanash A, Jenq R, et al. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 920-5. PMID 25687796 DOI: 10.1016/j.bbmt.2015.01.024  0.68
2015 Hobbs GS, Hamdi A, Hilden PD, Goldberg JD, Poon ML, Ledesma C, Devlin SM, Rondon G, Papadopoulos EB, Jakubowski AA, O'Reilly RJ, Champlin RE, Giralt S, Perales MA, Kebriaei P. Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone Marrow Transplantation. 50: 493-8. PMID 25621808 DOI: 10.1038/bmt.2014.302  0.68
2015 Gupta MP, Coombs P, Prockop SE, Hasan AA, Doubrovina E, O'Reilly RJ, Cohen SH, Park SS, Kiss S. Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surgery, Lasers & Imaging Retina. 46: 80-2. PMID 25559515 DOI: 10.3928/23258160-20150101-14  0.52
2015 Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, Goldberg JD, Hanash A, Hsu K, Jenq R, Perales MA, Sauter C, van den Brink MR, Young JW, Brentjens R, et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 125: 199-205. PMID 25377785 DOI: 10.1182/blood-2014-06-584789  0.68
2015 Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, Scaradavou A, Kernan NA, O'Reilly RJ, Giralt S, Jakubowski A, Koehne G, Papadopoulos EB, Ponce DM, Sauter C, et al. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leukemia & Lymphoma. 56: 1799-805. PMID 25224458 DOI: 10.3109/10428194.2014.963079  0.68
2014 Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. The New England Journal of Medicine. 371: 434-46. PMID 25075835 DOI: 10.1056/NEJMoa1401177  0.68
2014 Veomett N, Dao T, Liu H, Xiang J, Pankov D, Dubrovsky L, Whitten JA, Park SM, Korontsvit T, Zakhaleva V, Casey E, Curcio M, Kharas MG, O'Reilly RJ, Liu C, et al. Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4036-46. PMID 24850840 DOI: 10.1158/1078-0432.CCR-13-2756  0.68
2014 Dubrovsky L, Pankov D, Brea EJ, Dao T, Scott A, Yan S, O'Reilly RJ, Liu C, Scheinberg DA. A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood. 123: 3296-304. PMID 24723681 DOI: 10.1182/blood-2014-01-549022  0.68
2014 Shono Y, Tuckett AZ, Ouk S, Liou HC, Altan-Bonnet G, Tsai JJ, Oyler JE, Smith OM, West ML, Singer NV, Doubrovina E, Pankov D, Undhad CV, Murphy GF, Lezcano C, et al. A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity. Cancer Discovery. 4: 578-91. PMID 24550032 DOI: 10.1158/2159-8290.CD-13-0585  0.52
2014 Olson AL, Dahi PB, Zheng J, Devlin SM, Lubin M, Gonzales AM, Giralt SA, Perales MA, Papadopoulos EB, Ponce DM, Young JW, Kernan NA, Scaradavou A, O'Reilly RJ, Small TN, et al. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 787-93. PMID 24548875 DOI: 10.1016/j.bbmt.2014.02.010  0.68
2014 Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. The Journal of Allergy and Clinical Immunology. 133: 1092-8. PMID 24290292 DOI: 10.1016/j.jaci.2013.09.044  0.68
2014 Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, et al. Primary Immune Deficiency Treatment Consortium (PIDTC) report. The Journal of Allergy and Clinical Immunology. 133: 335-47. PMID 24139498 DOI: 10.1016/j.jaci.2013.07.052  0.68
2013 Giulino-Roth L, Ricafort R, Kernan NA, Small TN, Trippett TM, Steinherz PG, Prockop SE, Scaradavou A, Chiu M, O'Reilly RJ, Boulad F. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation. Pediatric Blood & Cancer. 60: 2018-24. PMID 24038967 DOI: 10.1002/pbc.24722  0.68
2013 Ballew BJ, Joseph V, De S, Sarek G, Vannier JB, Stracker T, Schrader KA, Small TN, O'Reilly R, Manschreck C, Harlan Fleischut MM, Zhang L, Sullivan J, Stratton K, Yeager M, et al. A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. Plos Genetics. 9: e1003695. PMID 24009516 DOI: 10.1371/journal.pgen.1003695  0.68
2013 Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. Journal of Clinical Immunology. 33: 1156-64. PMID 23818196 DOI: 10.1007/s10875-013-9917-y  0.68
2013 Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, et al. Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Science Translational Medicine. 5: 176ra33. PMID 23486779 DOI: 10.1126/scitranslmed.3005661  0.52
2013 Bayraktar UD, de Lima M, Saliba RM, Maloy M, Castro-Malaspina HR, Chen J, Rondon G, Chiattone A, Jakubowski AA, Boulad F, Kernan NA, O'Reilly RJ, Champlin RE, Giralt S, Andersson BS, et al. Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 898-903. PMID 23467126 DOI: 10.1016/j.bbmt.2013.02.018  0.68
2013 Ponce DM, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, Goldberg JD, Hanash AM, Jakubowski A, Jenq R, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, O'Reilly RJ, et al. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 904-11. PMID 23416854 DOI: 10.1016/j.bbmt.2013.02.008  0.68
2013 Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq R, Koehne G, Papadopoulos EB, van den Brink MR, Young JW, et al. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 208-13. PMID 22982534 DOI: 10.1016/j.bbmt.2012.09.003  0.68
2012 Doubrovina E, Carpenter T, Pankov D, Selvakumar A, Hasan A, O'Reilly RJ. Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias. Blood. 120: 1633-46. PMID 22623625 DOI: 10.1182/blood-2011-11-394619  0.52
2012 Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Small TN, Kobos R, Castro-Malaspina H, Araten D, DiMichele D, O'Reilly RJ, Boulad F. Paroxysmal nocturnal hemoglobinuria in pediatric patients. Pediatric Blood & Cancer. 59: 525-9. PMID 22147651 DOI: 10.1002/pbc.23410  0.68
2012 Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, Hedvat C, Chou JF, Heller G, Barker JN, Boulad F, Castro-Malaspina H, George D, Jakubowski A, Koehne G, et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood. 119: 2644-56. PMID 22138512 DOI: 10.1182/blood-2011-08-371971  0.68
2012 Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 473-80. PMID 22079789 DOI: 10.1016/j.bbmt.2011.11.009  0.68
2012 Keever-Taylor CA, Devine SM, Soiffer RJ, Mendizabal A, Carter S, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Goldstein SC, Stadtmauer EA, O'Reilly RJ. Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 690-7. PMID 21875505 DOI: 10.1016/j.bbmt.2011.08.017  0.68
2012 Tarek N, Kernan NA, Prockop SE, Scaradavou A, Small TN, O'Reilly RJ, Boulad F. T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia. Bone Marrow Transplantation. 47: 744-6. PMID 21785471 DOI: 10.1038/bmt.2011.142  0.68
2011 O'Reilly RJ, Hasan A, Doubrovina E, Koehne G, Prockop S. Novel strategies for adoptive therapy following HLA disparate transplants. Best Practice & Research. Clinical Haematology. 24: 381-91. PMID 21925091 DOI: 10.1016/j.beha.2011.06.001  0.52
2011 Rappeport JM, O'Reilly RJ, Kapoor N, Parkman R. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Hematology/Oncology Clinics of North America. 25: 17-30. PMID 21236387 DOI: 10.1016/j.hoc.2010.11.002  0.32
2011 Ponce DM, Zheng J, Gonzales AM, Lubin M, Heller G, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq RR, Koehne G, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, et al. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1316-26. PMID 21232625 DOI: 10.1016/j.bbmt.2011.01.006  0.68
2011 Jakubowski AA, Small TN, Kernan NA, Castro-Malaspina H, Collins N, Koehne G, Hsu KC, Perales MA, Papanicolaou G, van den Brink MR, O'Reilly RJ, Young JW, Papadopoulos EB. T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1335-42. PMID 21232623 DOI: 10.1016/j.bbmt.2011.01.005  0.68
2010 Barker JN, Doubrovina E, Sauter C, Jaroscak JJ, Perales MA, Doubrovin M, Prockop SE, Koehne G, O'Reilly RJ. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 116: 5045-9. PMID 20826724 DOI: 10.1182/blood-2010-04-281873  0.68
2010 Eldjerou LK, Chaudhury S, Baisre-de Leon A, He M, Arcila ME, Heller G, O'Reilly RJ, Barker JN, Moore MA. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 116: 3999-4006. PMID 20587781 DOI: 10.1182/blood-2010-03-276212  0.4
2010 O'Reilly RJ, Dao T, Koehne G, Scheinberg D, Doubrovina E. Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. Seminars in Immunology. 22: 162-72. PMID 20537908 DOI: 10.1016/j.smim.2010.02.003  0.52
2010 Rappeport JM, O'Reilly RJ, Kapoor N, Parkman R. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Immunology and Allergy Clinics of North America. 30: 17-30. PMID 20113884 DOI: 10.1016/j.iac.2009.10.002  0.32
2010 Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, et al. Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplantation. 45: 1408-16. PMID 20062091 DOI: 10.1038/bmt.2009.371  0.68
2009 Hasan AN, Selvakumar A, Doubrovina E, Riviere I, Sadelain MW, O'Reilly RJ. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies. Discovery Medicine. 8: 210-8. PMID 20040272  0.68
2009 Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, et al. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. The Journal of Allergy and Clinical Immunology. 124: 1152-60.e12. PMID 20004776 DOI: 10.1016/j.jaci.2009.10.022  0.68
2009 Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung NK, Hsu KC. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7330-4. PMID 19934297 DOI: 10.1158/1078-0432.CCR-09-1720  0.68
2009 Hasan AN, Kollen WJ, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly RJ. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. Journal of Immunology (Baltimore, Md. : 1950). 183: 2837-50. PMID 19635907 DOI: 10.4049/jimmunol.0804178  0.68
2009 Yu J, Venstrom JM, Liu XR, Pring J, Hasan RS, O'Reilly RJ, Hsu KC. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood. 113: 3875-84. PMID 19179302 DOI: 10.1182/blood-2008-09-177055  0.4
2008 Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. The Journal of Allergy and Clinical Immunology. 122: 1087-96. PMID 18992926 DOI: 10.1016/j.jaci.2008.09.045  0.68
2008 Pao M, Papadopoulos EB, Chou J, Glenn H, Castro-Malaspina H, Jakubowski AA, Kernan NA, Perales MA, Prokop S, Scaradavou A, VanDenBrink MR, Young JW, O'Reilly RJ, Small TN. Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1022-30. PMID 18721765 DOI: 10.1016/j.bbmt.2008.06.012  0.68
2008 Castro-Malaspina H, Jabubowski AA, Papadopoulos EB, Boulad F, Young JW, Kernan NA, Perales MA, Small TN, Hsu K, Chiu M, Heller G, Collins NH, Jhanwar SC, van den Brink M, Nimer SD, et al. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 458-68. PMID 18342789 DOI: 10.1016/j.bbmt.2008.02.006  0.68
2008 Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O'Reilly RJ, Boulad F. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. British Journal of Haematology. 140: 644-55. PMID 18302713 DOI: 10.1111/j.1365-2141.2007.06975.x  0.68
2007 Doubrovin MM, Doubrovina ES, Zanzonico P, Sadelain M, Larson SM, O'Reilly RJ. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Research. 67: 11959-69. PMID 18089827 DOI: 10.1158/0008-5472.CAN-07-1250  0.68
2007 Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1313-23. PMID 17950918 DOI: 10.1016/j.bbmt.2007.07.006  0.68
2007 O'Reilly RJ, Doubrovina E, Trivedi D, Hasan A, Kollen W, Koehne G. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunologic Research. 38: 237-50. PMID 17917029  0.52
2007 Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC, Perales MA, Collins N, Cisek C, Chiu M, van den Brink MR, O'Reilly RJ, Papadopoulos EB. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood. 110: 4552-9. PMID 17717135 DOI: 10.1182/blood-2007-06-093880  0.68
2007 Perales MA, Ishill N, Lomazow WA, Weinstock DM, Papadopoulos EB, Dastigir H, Chiu M, Boulad F, Castro-Malaspina HR, Heller G, Jakubowski AA, O'Reilly RJ, Small TN, Young JW, Kernan NA. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplantation. 40: 481-6. PMID 17618322 DOI: 10.1038/sj.bmt.1705762  0.68
2007 Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O'Reilly RJ, Sklar CA. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplantation. 40: 29-35. PMID 17468769 DOI: 10.1038/sj.bmt.1705694  0.68
2007 Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 235-44. PMID 17241929 DOI: 10.1016/j.bbmt.2006.10.005  0.68
2006 Jaffe D, Papadopoulos EB, Young JW, O'reilly RJ, Prockop S, Kernan NA, Jakubowski A, Boulad F, Perales MA, Castro-Malaspina H, Small TN. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood. 108: 2470-5. PMID 16763208 DOI: 10.1182/blood-2006-04-006981  0.68
2006 Zanzonico P, Koehne G, Gallardo HF, Doubrovin M, Doubrovina E, Finn R, Blasberg RG, Riviere I, O'Reilly RJ, Sadelain M, Larson SM. [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. European Journal of Nuclear Medicine and Molecular Imaging. 33: 988-97. PMID 16607546 DOI: 10.1007/s00259-005-0057-3  0.68
2005 Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 105: 4878-84. PMID 15731175 DOI: 10.1182/blood-2004-12-4825  0.48
2005 Trivedi D, Williams RY, O'Reilly RJ, Koehne G. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. Blood. 105: 2793-801. PMID 15514011 DOI: 10.1182/blood-2003-05-1433  0.48
2004 Camacho RE, Wnek R, Shah K, Zaller DM, O'Reilly RJ, Collins N, Fitzgerald-Bocarsly P, Koo GC. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cellular Immunology. 232: 86-95. PMID 15922719 DOI: 10.1016/j.cellimm.2005.02.003  0.32
2004 Doubrovina ES, Doubrovin MM, Lee S, Shieh JH, Heller G, Pamer E, O'Reilly RJ. In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7207-19. PMID 15534094 DOI: 10.1158/1078-0432.CCR-04-1040  0.68
2004 Dupont J, Wang X, Marshall DS, Leitao M, Hedvat CV, Hummer A, Thaler H, O'Reilly RJ, Soslow RA. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecologic Oncology. 94: 449-55. PMID 15297187 DOI: 10.1016/j.ygyno.2004.05.014  0.68
2004 Yuan RR, Wong P, McDevitt MR, Doubrovina E, Leiner I, Bornmann W, O'reilly R, Pamer EG, Scheinberg DA. Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers. Blood. 104: 2397-402. PMID 15217835 DOI: 10.1182/blood-2004-01-0324  0.68
2003 Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). 171: 6891-9. PMID 14662896  0.56
2003 Burke JM, Caron PC, Papadopoulos EB, Divgi CR, Sgouros G, Panageas KS, Finn RD, Larson SM, O'Reilly RJ, Scheinberg DA, Jurcic JG. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias Bone Marrow Transplantation. 32: 549-556. PMID 12953125 DOI: 10.1038/sj.bmt.1704201  0.68
2003 Alpdogan O, Muriglan SJ, Kappel BJ, Doubrovina E, Schmaltz C, Schiro R, Eng JM, Greenberg AS, Willis LM, Rotolo JA, O'Reilly RJ, van den Brink MR. Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation. 75: 1977-83. PMID 12829897 DOI: 10.1097/01.TP.0000070167.81584.A2  0.68
2003 Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes Nature Biotechnology. 21: 405-413. PMID 12652311 DOI: 10.1038/nbt805  0.68
2002 Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of Immunology (Baltimore, Md. : 1950). 169: 5118-29. PMID 12391228  0.52
2002 Lewin SR, Heller G, Zhang L, Rodrigues E, Skulsky E, van den Brink MR, Small TN, Kernan NA, O'Reilly RJ, Ho DD, Young JW. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood. 100: 2235-42. PMID 12200390  0.68
2002 Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG, Dupont B, O'Reilly RJ. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 99: 1730-40. PMID 11861290 DOI: 10.1182/blood.V99.5.1730  0.68
2001 Heath JA, Kurland G, Spray TL, Kernan NA, Small TN, Brochstein JA, Gillio AP, Boklan J, O'Reilly RJ, Boulad F. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. Transplantation. 72: 1986-90. PMID 11773900 DOI: 10.1097/00007890-200112270-00020  0.68
2000 Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J, Regan AD, Collins N, Auerbach AD, Kernan NA, O'Reilly RJ. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. British Journal of Haematology. 111: 1153-7. PMID 11167755 DOI: 10.1046/J.1365-2141.2000.02443.X  0.32
1999 Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401: 670-7. PMID 10537105 DOI: 10.1038/44334  0.68
1999 Prasad VK, Heller G, Kernan NA, O'Reilly RJ, Yang SY. The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles. Transplantation. 68: 1044-50. PMID 10532548 DOI: 10.1097/00007890-199910150-00024  0.4
1999 Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 77-85. PMID 10371359 DOI: 10.1053/BBMT.1999.V5.PM10371359  0.4
1990 Shank B, O'Reilly RJ, Cunningham I, Kernan N, Yaholom J, Brochstein J, Castro-Malaspina H, Kutcher GJ, Mohan R, Bonfiglio P. Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 18: 68-81. PMID 2247651 DOI: 10.1016/0167-8140(90)90180-5  0.68
1990 DiSanto JP, Keever CA, Small TN, Nicols GL, O'Reilly RJ, Flomenberg N. Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells. The Journal of Experimental Medicine. 171: 1697-704. PMID 2139699 DOI: 10.1084/JEM.171.5.1697  0.68
1989 Frame JN, Collins NH, Cartagena T, Waldmann H, O'Reilly RJ, Dupont B, Kernan NA. T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation. 47: 984-8. PMID 2660360 DOI: 10.1097/00007890-198906000-00013  0.32
1989 Bordignon C, Yu SF, Smith CA, Hantzopoulos P, Ungers GE, Keever CA, O'Reilly RJ, Gilboa E. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 6748-52. PMID 2549545 DOI: 10.1073/pnas.86.17.6748  0.68
1988 Shank B, Brochstein JA, Castro-Malaspina H, Yahalom J, Bonfiglio P, O'Reilly RJ. Immunosuppression prior to marrow transplantation for sensitized aplastic anemia patients: comparison of TLI with TBI. International Journal of Radiation Oncology, Biology, Physics. 14: 1133-41. PMID 3290168 DOI: 10.1016/0360-3016(88)90389-6  0.68
1986 O'Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Kernan N, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sanguinis. 51: 81-6. PMID 3532540 DOI: 10.1111/j.1423-0410.1986.tb02013.x  0.68
1984 Pollack MS, Chin-Louie J, Callaway C, Blanco MA, Slavin K, Sullivan K, O'Reilly RJ, Dupont B. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants. Journal of Clinical Immunology. 3: 341-51. PMID 6197424 DOI: 10.1007/BF00915795  0.32
1983 Lazar RM, Tamaroff M, Nir Y, Freund B, O'Reilly R, Kirkpatrick D, Kapoor N. Language recovery following isolation for severe combined immunodeficiency disease. Nature. 306: 54-5. PMID 27089556 DOI: 10.1038/306054a0  0.32
1983 Shank B, Chu FC, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid A, Bonfiglio P, Simpson L, O'Reilly RJ. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. International Journal of Radiation Oncology, Biology, Physics. 9: 1607-11. PMID 6358154 DOI: 10.1016/0360-3016(83)90412-1  0.68
1982 Incefy GS, O'Reilly RJ, Kapoor N, Iwata T, Good RA. In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency. Transplantation. 32: 299-305. PMID 6977211 DOI: 10.1097/00007890-198110000-00008  0.44
1982 Pahwa SG, Pahwa RN, Friedrich W, O'Reilly RJ, Good RA. Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients Proceedings of the National Academy of Sciences of the United States of America. 79: 2663-2667. PMID 6211673 DOI: 10.1073/pnas.79.8.2663  0.68
1982 Pollack MS, Kirkpatrick D, Kapoor N, Evans R, Dupont B, O'Reilly RJ. HLA typing of lymphocyte subpopulations for the identification of intrauterine-derived engrafted maternal cells in patients with severe combined immunodeficiency (SCID) Human Immunology. 5: 163. DOI: 10.1016/0198-8859(82)90100-8  0.32
1981 Shank B, Hopfan S, Kim JH, Chu FC, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, Simpson L, Reid A, Chui C, Mohan R, Finegan D, O'Reilly RJ. Hyperfractionated total body irradiation for bone marrow transplantation: I. Early results in leukemia patients. International Journal of Radiation Oncology, Biology, Physics. 7: 1109-15. PMID 7028698 DOI: 10.1016/0360-3016(81)90170-X  0.68
1981 Dupont B, O'Reilly RJ, Pollack MS, Good RA. Histocompatibility testing for clinical bone marrow transplantation and prospects for identification of donors other than HLA genotypically identical siblings. Haematology and Blood Transfusion. 25: 121-34. PMID 7021335 DOI: 10.1007/978-3-642-67319-1_12  0.68
1980 Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O'Reilly RJ. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation. 30: 331-4. PMID 6450472 DOI: 10.1097/00007890-198011000-00004  0.48
1979 Pollack MS, Yang SY, O'Neill GJ, O'Reilly RJ, Grossbard E, Kapoor N, Good RA, Dupont B. Bone marrow transplantation using typing for glyoxalase I as a tool in histocompatibility testing. Transplantation. 28: 156-8. PMID 384622 DOI: 10.1097/00007890-197908000-00019  0.52
1978 Pahwa R, Pahwa S, O'Reilly R, Good RA. Treatment of the immunodeficiency diseases - progress toward replacement therapy emphasizing cellular and macromolecular engineering Springer Seminars in Immunopathology. 1: 355-404. DOI: 10.1007/BF01857312  0.68
1977 Pahwa R, Pahwa S, Good RA, Incefy GS, O'Reilly RJ. Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency Proceedings of the National Academy of Sciences of the United States of America. 74: 3002-3005. PMID 331324 DOI: 10.1073/pnas.74.7.3002  0.68
1973 Gordon DS, Hunter RG, O'Reilly RJ, Conway BP. Pseudomonas aeruginosa allergy and humoral antibody-mediated hypersensitivity pneumonia. The American Review of Respiratory Disease. 108: 127-31. PMID 4197698 DOI: 10.1164/arrd.1973.108.1.127  0.68
Show low-probability matches.